Flemington, NJ, United States of America

Richard C Allen


Average Co-Inventor Count = 2.6

ph-index = 8

Forward Citations = 274(Granted Patents)


Location History:

  • Somerville, NJ (US) (1976)
  • Flemington, NJ (US) (1977 - 2006)

Company Filing History:


Years Active: 1976-2006

Loading Chart...
41 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Richard C. Allen

Introduction

Richard C. Allen, located in Flemington, NJ, is a prolific inventor with an impressive record of 41 patents to his name. His work primarily focuses on advancements in the field of psychiatry and pharmacology, where he has worked to develop novel methods and compounds for treating various medical conditions.

Latest Patents

Among his latest innovations, Allen has developed methods for treating schizophrenia. This invention provides strategies for addressing abnormal psychiatric states, particularly the negative symptoms of schizophrenia and the extrapyramidal side effects of antipsychotic drugs. His methods involve the administration of therapeutic cells that produce dopamine or its precursors, which are adhered to support matrices. These therapeutic cells may be coadministered with other cells that protect them from immune rejection and those that produce neurotrophic factors, ultimately improving the viability of the therapeutic cells.

Another significant patent by Allen concerns N-hydroxy-dibenzò[b,e]oxepinalkylamines. This invention relates to compounds that demonstrate utility as analgesics and topical anti-inflammatory agents, treating various dermatoses and conditions where the accumulation of cyclooxygenase and lipoxygenase metabolites is a contributing factor. These compounds exhibit potential therapeutic applications that could significantly benefit patients suffering from these conditions.

Career Highlights

Richard C. Allen has had a notable career, working for prominent institutions including Hoechst Roussel Pharmaceuticals and American Hoechst Corporation. His experiences in these companies have significantly contributed to his extensive knowledge and expertise in the pharmaceutical field.

Collaborations

Throughout his career, Allen has collaborated with various professionals, including notable coworkers such as Joseph T. Strupczewski and Beth A. Gardner. Their combined efforts have further propelled innovation and development in the treatments that Allen has pioneered.

Conclusion

Richard C. Allen continues to be an influential figure in the domain of psychiatric and pharmacological innovation. With a robust portfolio of patents and collaborations, he exemplifies the spirit of invention that drives advancements in medical science, offering hope for effective treatments for complex conditions such as schizophrenia. His work not only underscores the importance of research and development in medicine but also the significant impact that dedicated inventors can have on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…